Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen.
Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, Karsdal MA. Barascuk N, et al. Among authors: cao y. Clin Biochem. 2010 Jul;43(10-11):899-904. doi: 10.1016/j.clinbiochem.2010.03.012. Epub 2010 Apr 7. Clin Biochem. 2010. PMID: 20380828
Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen--A novel biomarker of atherosclerotic plaque remodeling.
Barascuk N, Vassiliadis E, Larsen L, Wang J, Zheng Q, Xing R, Cao Y, Crespo C, Lapret I, Sabatini M, Villeneuve N, Vilaine JP, Rasmussen LM, Register TC, Karsdal MA. Barascuk N, et al. Among authors: cao y. Clin Biochem. 2011 Jul;44(10-11):900-6. doi: 10.1016/j.clinbiochem.2011.04.004. Epub 2011 Apr 30. Clin Biochem. 2011. PMID: 21549691
A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M).
Leeming Dj, He Y, Veidal S, Nguyen Q, Larsen D, Koizumi M, Segovia-Silvestre T, Zhang C, Zheng Q, Sun S, Cao Y, Barkholt V, Hägglund P, Bay-Jensen A, Qvist P, Karsdal M. Leeming Dj, et al. Among authors: cao y. Biomarkers. 2011 Nov;16(7):616-28. doi: 10.3109/1354750X.2011.620628. Epub 2011 Oct 11. Biomarkers. 2011. PMID: 21988680
Comparing demographic/clinical characteristics, health care resource utilization, and costs among patients with type 2 diabetes and established atherosclerotic cardiovascular disease with and without the use of cardioprotective medications.
Dunn TJ, Cao Y, Xie L, Guevarra M, Mitri J. Dunn TJ, et al. Among authors: cao y. J Manag Care Spec Pharm. 2025 Jan 17:1-10. doi: 10.18553/jmcp.2025.24251. Online ahead of print. J Manag Care Spec Pharm. 2025. PMID: 39823186
28,800 results
You have reached the last available page of results. Please see the User Guide for more information.